Cell-Based Therapy for Neural Disorders - Anticipating Challenges

被引:34
作者
Chiu, Arlene Y. [1 ]
Rao, Mahendra S. [2 ]
机构
[1] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA USA
[2] Life Technol Corp, Carlsbad, CA USA
关键词
Pluripotent stem cells; ESC; CNS roadblocks; EMBRYONIC STEM-CELLS; HOMOLOGOUS RECOMBINATION; DIRECT CONVERSION; FIBROBLASTS; PLASTICITY; MUTATION; NEURONS; INJURY; CNS;
D O I
10.1007/s13311-011-0066-9
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Neurological syndromes, such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, Huntington's disease, amyotrophic lateral sclerosis, and lysosomal storage disorders, such as Battens disease, are devastating because they result in increasing loss of cognitive and physical function. Sadly, no drugs are currently available to halt their progression. The relative paucity of curative approaches for these and other conditions of the nervous system have led to a widespread evaluation of alternative treatment modalities including cell-based interventions. Several cell types have been tested successfully in animal models where safety and efficacy have been demonstrated. Early clinical trials have also been initiated in humans, and some have shown a degree of success albeit on a more limited scale than in animal experiments. Recent demonstrations that pluripotent stem cells, such as embryonic stem cells and induced pluripotent stem cells, can differentiate into a variety of specific neural phenotypes has stimulated worldwide enthusiasm for developing cell-based intervention of neurological disease. Indeed, several groups are preparing investigational new drug applications to treat disorders as diverse as macular degeneration, lysosomal storage diseases, and Parkinson's disease. It is noteworthy that cell replacement therapies for neurological conditions face key challenges, some of which are unique, because of the development and organization of the nervous system, its metabolism, and connectivity. Choice of the cell (or cells), the process of manufacturing them, defining the delivery pathway, developing and testing in an appropriate preclinical model, selecting a patient population, and visualizing and following or monitoring patients all pose specific issues as related to the central and peripheral nervous systems. In this review, we address a myriad of challenges that are solvable, but require careful planning and attention to the special demands of the human nervous system.
引用
收藏
页码:744 / 752
页数:9
相关论文
共 27 条
  • [1] Translating Stem Cell Studies to the Clinic for CNS Repair: Current State of the Art and the Need for a Rosetta Stone
    Aboody, Karen
    Capela, Alexandra
    Niazi, Nilofar
    Stern, Jeffrey H.
    Temple, Sally
    [J]. NEURON, 2011, 70 (04) : 597 - 613
  • [2] Isolation and Production of Cells Suitable for Human Therapy: Challenges Ahead
    Ahrlund-Richter, Lars
    De Luca, Michele
    Marshak, Daniel R.
    Munsie, Megan
    Veiga, Anna
    Rao, Mahendra
    [J]. CELL STEM CELL, 2009, 4 (01) : 20 - 26
  • [3] Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]
  • [4] Multipotent Adult Progenitor Cells Prevent Macrophage-Mediated Axonal Dieback and Promote Regrowth after Spinal Cord Injury
    Busch, Sarah A.
    Hamilton, Jason A.
    Horn, Kevin P.
    Cuascut, Fernando X.
    Cutrone, Rochelle
    Lehman, Nicholas
    Deans, Robert J.
    Ting, Anthony E.
    Mays, Robert W.
    Silver, Jerry
    [J]. JOURNAL OF NEUROSCIENCE, 2011, 31 (03) : 944 - 953
  • [5] Developing safe therapies from human pluripotent stem cells
    Carpenter, Melissa K.
    Frey-Vasconcells, Joyce
    Rao, Mahendra S.
    [J]. NATURE BIOTECHNOLOGY, 2009, 27 (07) : 606 - 613
  • [6] Experience Dictates Stem Cell Fate in the Adult Hippocampus
    Dranovsky, Alex
    Picchini, Alyssa M.
    Moadel, Tiffany
    Sisti, Alexander C.
    Yamada, Atsushi
    Kimura, Shioko
    Leonardo, E. David
    Hen, Rene
    [J]. NEURON, 2011, 70 (05) : 908 - 923
  • [7] Concise Review: Stem Cells As an Emerging Platform for Antibody Therapy of Cancer
    Frank, Richard T.
    Najbauer, Joseph
    Aboody, Karen S.
    [J]. STEM CELLS, 2010, 28 (11) : 2084 - 2087
  • [8] Gilbert SF, 2003, INT J DEV BIOL, V47, P467
  • [9] MOTOR-NEURON DEGENERATION IN MICE THAT EXPRESS A HUMAN CU,ZN SUPEROXIDE-DISMUTASE MUTATION
    GURNEY, ME
    PU, HF
    CHIU, AY
    DALCANTO, MC
    POLCHOW, CY
    ALEXANDER, DD
    CALIENDO, J
    HENTATI, A
    KWON, YW
    DENG, HX
    CHEN, WJ
    ZHAI, P
    SUFIT, RL
    SIDDIQUE, T
    [J]. SCIENCE, 1994, 264 (5166) : 1772 - 1775
  • [10] Therapeutic Targeting of Melanoma Cells Using Neural Stem Cells Expressing Carboxylesterase, a CPT-11 Activating Enzyme
    Gutova, Margarita
    Najbauer, Joseph
    Chen, Mike Y.
    Potter, Philip M.
    Kim, Seung U.
    Aboody, Karen S.
    [J]. CURRENT STEM CELL RESEARCH & THERAPY, 2010, 5 (03) : 273 - 276